Peringkat dalam Saham
#38936
Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a... Founded in 1998 and headquartered in Berlin, Germany, Epigenomics AG is a molecular diagnostics company dedicated to the early detection of cancer through liquid biopsy methods. Its primary offering, Epi proColon, is a blood-based assay specifically developed for the early identification of colorectal cancer, distributed across the United States, Europe, and China. The company's portfolio further encompasses a blood test for hepatocellular carcinoma and Epi BiSKit, a pre-analytical solution providing reagents essential for preparing bisulfite-converted DNA. Epigenomics' research and development initiatives are focused on pinpointing relevant biomarkers in human tissue and subsequently creating and securing patents for associated in vitro diagnostic blood tests.
Harga Saham
$0.83030862
Terakhir disinkronkan: 2024-06-27
Kapitalisasi Pasar
$726.64K
Perubahan (1 hari)
-1.35%
Perubahan (1 tahun)
0.00%
Perdagangan Epigenomics AG (ECX)
Harga ECX dengan kapitalisasi pasar B
Kapitalisasi pasar dari Epigenomics AG(ECX)
Kapitalisasi Pasar: $726.64K
Per August 2026, Epigenomics AG memiliki kapitalisasi pasar sebesar $726.64K. Ini menjadikan Epigenomics AG sebagai perusahaan 38936th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Epigenomics AG dari 2014 hingga 2026
ECX dibandingkan dengan 5 teratas stocks paling populer
| Harga ECX |
|
Aset B |
Pasar B |
Hasil |
|
|
|
|
$5.470T
|
+752,711,453.14%
|
|
|
|
|
$4.467T
|
+614,753,146.04%
|
|
|
|
|
$4.174T
|
+574,424,088.62%
|
|
|
|
|
$3.700T
|
+509,200,320.84%
|
|
|
|
|
$2.854T
|
+392,811,288.04%
|
